Back to funds

GordonMD Global Investments LP

Updated 6 days ago

Managed by Gordonmd Global Investments Lp • Latest filing Q3 2026

Portfolio value
$166.5M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$139.5M
Q1 2026$143.6M
Q2 2026$206.7M
Q3 2026$166.5M

Top holdings

14 positions as of Q3 2026

View filing
Q

PYXIS ONCOLOGY INC

Value
$36.2M
Shares
15.54M
% Port
21.75%
?
2.N/A

KYVERNA THERAPEUTICS INC

Value
$30.7M
Shares
4.52M
% Port
18.47%
T

TEVA PHARMACEUTICAL INDS LTD

Value
$15M
Shares
379.5K
% Port
9.03%
C

CELLDEX THERAPEUTICS INC NEW

Value
$9.1M
Shares
279.7K
% Port
5.45%
T

TANGO THERAPEUTICS INC

Value
$9M
Shares
1.85M
% Port
5.42%
V

VIR BIOTECHNOLOGY INC

Value
$9M
Shares
803.6K
% Port
5.40%
A

ADARX PHARMACEUTICALS INC

Value
$9M
Shares
450.0K
% Port
5.39%
A

ALLOGENE THERAPEUTICS INC

Value
$8.5M
Shares
5.30M
% Port
5.09%
B

BAUSCH PLUS LOMB CORP

Value
$8.1M
Shares
475.5K
% Port
4.86%
E

EDITAS MEDICINE INC

Value
$8M
Shares
3.13M
% Port
4.83%
I

INCYTE CORP

Value
$6.2M
Shares
51.1K
% Port
3.72%
T

TAYSHA GENE THERAPIES INC

Value
$6.2M
Shares
248.0K
% Port
3.72%
A

AMGEN INC

Value
$6.1M
Shares
14.5K
% Port
3.67%
S

SCHOLAR ROCK HLDG CORP

Value
$5.3M
Shares
110.5K
% Port
3.21%

Explore